文献速递腹部技术与安全US

慢性乙型肝炎合并肝细胞癌患者术前无创肝纤维化评估:二维剪切波弹性成像与血清肝纤维化模型的比较

Preoperative noninvasive assessment for liver fibrosis in hepatocellular carcinoma patients with chronic hepatitis B: Comparison of two-dimensional shear-wave elastography with serum liver fibrosis models.
PubMed 文献 · Eur J Radiol · 2020-11-02

纳入100例首次诊断为肝细胞癌的慢性乙型肝炎患者,术前行二维剪切波弹性成像(2D-SWE)并计算Forns评分、APRI和FIB-4。2D-SWE诊断显著纤维化(F≥2)和肝硬化(F=4)的AUC分别为0.983和0.896,均显著高于三种血清模型(p<0.05);Forns诊断显著纤维化的AUC与APRI、FIB-4无统计学差异(p>0.05),诊断肝硬化时显著更高(p<0.05)。结论认为2D-SWE是术前无创评估肝纤维化的可靠方法,诊断准确性明显高于血清肝纤维化模型。

要点

  • 2D-SWE诊断显著纤维化(F≥2)的AUC为0.983,诊断肝硬化(F=4)的AUC为0.896。
  • 2D-SWE诊断显著纤维化和肝硬化的AUC均显著高于Forns、APRI和FIB-4(p<0.05)。
  • Forns诊断显著纤维化的AUC与APRI、FIB-4无统计学差异(p>0.05),诊断肝硬化时显著更高(p<0.05)。

核心结论

  • 2D-SWE是慢性乙型肝炎合并肝细胞癌患者术前无创评估肝纤维化的可靠方法,诊断准确性明显高于血清肝纤维化模型。

研究设计与样本

  • 纳入100例首次诊断为肝细胞癌的慢性乙型肝炎患者,均在肝切除术前接受2D-SWE测量。
  • 以受试者工作特征(ROC)分析评估2D-SWE与血清模型(Forns评分、APRI、FIB-4)诊断肝纤维化的性能。

诊断标准与关键数值

  • 诊断显著纤维化(F≥2)的AUC:2D-SWE 0.983、Forns 0.757、APRI 0.745、FIB-4 0.710。
  • 诊断肝硬化(F=4)的AUC:2D-SWE 0.896、Forns 0.718、APRI 0.626、FIB-4 0.575。
  • 2D-SWE诊断显著纤维化和肝硬化的AUC均显著高于血清肝纤维化模型(p<0.05)。
  • Forns诊断显著纤维化(F≥2)的AUC与APRI和FIB-4无统计学差异(p>0.05);诊断肝硬化(F=4)时Forns的AUC显著更高(p<0.05)。

临床应用与阅片要点

  • 在慢性乙型肝炎合并肝细胞癌患者术前评估中,可参考2D-SWE的AUC(显著纤维化0.983、肝硬化0.896)判断肝纤维化程度。
  • 血清模型中Forns诊断肝硬化的AUC为0.718,高于APRI的0.626和FIB-4的0.575(p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the diagnostic performance of two-dimensional shear-wave elastography (2D-SWE) in hepatocellular carcinoma patients with chronic hepatitis B adapted to hepatectomy comparing to serum liver fibrosis models.

METHOD: 100 patients with chronic hepatitis B who first diagnosed with hepatocellular carcinoma and had undergone 2D-SWE measurements before the hepatectomy were included. The performance of 2D-SWE and serum models in the diagnosis of liver fibrosis was assessed using receiver operating characteristic (ROC) analyses.

RESULTS: The areas under ROC (AUCs) for 2D-SWE, Forns score, aspartate transaminase-to-platelet ratio index (APRI) and Fibrosis 4 Score (FIB-4) were 0.983, 0.757, 0.745, 0.710 in the diagnosis of significant fibrosis (F ≥ 2) respectively, and 0.896, 0.718, 0.626, 0.575 in the diagnosis of cirrhosis (F = 4) respectively. The AUCs for 2D-SWE in the diagnosis of significant fibrosis and cirrhosis were significantly higher than those for the serum fibrosis models (p < 0.05). The AUCs of Forns in the diagnosis of significant fibrosis (F ≥ 2) showed no statistical differences (p > 0.05) with those of APRI and FIB-4 while in the diagnosis of cirrhosis (F = 4), they are significantly higher (p < 0.05).

CONCLUSIONS: 2D-SWE is a reliable method for preoperative noninvasive assessment of liver fibrosis in HCC patients with CHB, with notably higher diagnostic accuracy than serum liver fibrosis models.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Chen S, Jiang T. Preoperative noninvasive assessment for liver fibrosis in hepatocellular carcinoma patients with chronic hepatitis B: Comparison of two-dimensional shear-wave elastography with serum liver fibrosis models. Eur J Radiol. 2020. PMID: 33160197. doi:10.1016/j.ejrad.2020.109386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。